The Power of Innovation: How Technology Facilitates Market & Patient Access

FiercePharma sits down with the President of Xcenda, Kristine Flemister, to discuss how technology is helping to commercialize new therapies, develop value propositions and expand market access.

Read more on

Suggested Articles

Download our solutions overview to discover how CoverMyMeds can make a difference for your brand.

In a bladder cancer field chock-full of checkpoint inhibitors, Pfizer and Merck KGaA’s Bavencio has a chance to get ahead thanks to new data.

The FDA backtracked on its earlier testing and found NDMA contamination in the extended release formulation of certain generic versions of metformin.